Pierluigi Porcu, MD and Steven Horwitz, MD, PhD

In this episode, “Evolving Approaches in T-Cell Lymphoma”, Pierluigi Porcu, MD and Steven Horwitz, MD, PhD focus on new combination strategies and progress with immunotherapy in peripheral and cutaneous T-cell lymphomas.

Novel therapies used in relapsed/refractory disease (e.g., brentuximab vedotin, romidepsin) are being investigated in combination with frontline chemotherapy and in consolidation settings. For immunotherapy trials, an important goal is to better characterize responders.

Share this story, choose your platform!